These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 27513187)

  • 1. Exosomes derived from human mesenchymal stem cells promote gastric cancer cell growth and migration via the activation of the Akt pathway.
    Gu H; Ji R; Zhang X; Wang M; Zhu W; Qian H; Chen Y; Jiang P; Xu W
    Mol Med Rep; 2016 Oct; 14(4):3452-8. PubMed ID: 27513187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATG4A promotes tumor metastasis by inducing the epithelial-mesenchymal transition and stem-like properties in gastric cells.
    Yang SW; Ping YF; Jiang YX; Luo X; Zhang X; Bian XW; Yu PW
    Oncotarget; 2016 Jun; 7(26):39279-39292. PubMed ID: 27276686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumorigenic hybrids between mesenchymal stem cells and gastric cancer cells enhanced cancer proliferation, migration and stemness.
    Xue J; Zhu Y; Sun Z; Ji R; Zhang X; Xu W; Yuan X; Zhang B; Yan Y; Yin L; Xu H; Zhang L; Zhu W; Qian H
    BMC Cancer; 2015 Oct; 15():793. PubMed ID: 26498753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-treatment of human umbilical cord-derived mesenchymal stem cells with interleukin-6 abolishes their growth-promoting effect on gastric cancer cells.
    Wang M; Cai J; Huang F; Zhu M; Zhang Q; Yang T; Zhang X; Qian H; Xu W
    Int J Mol Med; 2015 Feb; 35(2):367-75. PubMed ID: 25483835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-17B activated mesenchymal stem cells enhance proliferation and migration of gastric cancer cells.
    Bie Q; Zhang B; Sun C; Ji X; Barnie PA; Qi C; Peng J; Zhang D; Zheng D; Su Z; Wang S; Xu H
    Oncotarget; 2017 Mar; 8(12):18914-18923. PubMed ID: 28145881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YAP signaling in gastric cancer-derived mesenchymal stem cells is critical for its promoting role in cancer progression.
    Pan Z; Tian Y; Zhang B; Zhang X; Shi H; Liang Z; Wu P; Li R; You B; Yang L; Mao F; Qian H; Xu W
    Int J Oncol; 2017 Oct; 51(4):1055-1066. PubMed ID: 28848999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS and NCI-N78 cells.
    Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Pan SY; Chen XW; Zhou SF
    Drug Des Devel Ther; 2015; 9():1293-318. PubMed ID: 25767376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-374 mediates the malignant transformation of gastric cancer-associated mesenchymal stem cells in an experimental rat model.
    Ji R; Zhang X; Qian H; Gu H; Sun Z; Mao F; Yan Y; Chen J; Liang Z; Xu W
    Oncol Rep; 2017 Sep; 38(3):1473-1481. PubMed ID: 28731132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-associated macrophages-derived exosomes promote the migration of gastric cancer cells by transfer of functional Apolipoprotein E.
    Zheng P; Luo Q; Wang W; Li J; Wang T; Wang P; Chen L; Zhang P; Chen H; Liu Y; Dong P; Xie G; Ma Y; Jiang L; Yuan X; Shen L
    Cell Death Dis; 2018 Apr; 9(4):434. PubMed ID: 29567987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zipper-interacting protein kinase promotes epithelial-mesenchymal transition, invasion and metastasis through AKT and NF-kB signaling and is associated with metastasis and poor prognosis in gastric cancer patients.
    Li J; Deng Z; Wang Z; Wang D; Zhang L; Su Q; Lai Y; Li B; Luo Z; Chen X; Chen Y; Huang X; Ma J; Wang W; Bi J; Guan X
    Oncotarget; 2015 Apr; 6(10):8323-38. PubMed ID: 25831050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-derived exosomes induce N2 polarization of neutrophils to promote gastric cancer cell migration.
    Zhang X; Shi H; Yuan X; Jiang P; Qian H; Xu W
    Mol Cancer; 2018 Oct; 17(1):146. PubMed ID: 30292233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric cancer-derived mesenchymal stem cells prompt gastric cancer progression through secretion of interleukin-8.
    Li W; Zhou Y; Yang J; Zhang X; Zhang H; Zhang T; Zhao S; Zheng P; Huo J; Wu H
    J Exp Clin Cancer Res; 2015 May; 34(1):52. PubMed ID: 25986392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocyte growth factor (HGF) upregulates heparanase expression via the PI3K/Akt/NF-κB signaling pathway for gastric cancer metastasis.
    Hao NB; Tang B; Wang GZ; Xie R; Hu CJ; Wang SM; Wu YY; Liu E; Xie X; Yang SM
    Cancer Lett; 2015 May; 361(1):57-66. PubMed ID: 25727320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K/AKT signaling pathway.
    Zang M; Zhang B; Zhang Y; Li J; Su L; Zhu Z; Gu Q; Liu B; Yan M
    PLoS One; 2014; 9(11):e112908. PubMed ID: 25398131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer.
    Lu WD; Zuo Y; Xu Z; Zhang M
    World J Gastroenterol; 2015 Apr; 21(15):4564-73. PubMed ID: 25914465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton pump inhibitor pantoprazole abrogates adriamycin-resistant gastric cancer cell invasiveness via suppression of Akt/GSK-β/β-catenin signaling and epithelial-mesenchymal transition.
    Zhang B; Yang Y; Shi X; Liao W; Chen M; Cheng AS; Yan H; Fang C; Zhang S; Xu G; Shen S; Huang S; Chen G; Lv Y; Ling T; Zhang X; Wang L; Zhuge Y; Zou X
    Cancer Lett; 2015 Jan; 356(2 Pt B):704-12. PubMed ID: 25449432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomes derived from gastric cancer cells activate NF-κB pathway in macrophages to promote cancer progression.
    Wu L; Zhang X; Zhang B; Shi H; Yuan X; Sun Y; Pan Z; Qian H; Xu W
    Tumour Biol; 2016 Sep; 37(9):12169-12180. PubMed ID: 27220495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-338-3p inhibits epithelial-mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signaling.
    Huang N; Wu Z; Lin L; Zhou M; Wang L; Ma H; Xia J; Bin J; Liao Y; Liao W
    Oncotarget; 2015 Jun; 6(17):15222-34. PubMed ID: 25945841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer.
    Toiyama Y; Yasuda H; Saigusa S; Matushita K; Fujikawa H; Tanaka K; Mohri Y; Inoue Y; Goel A; Kusunoki M
    Int J Cancer; 2012 Jun; 130(12):2912-21. PubMed ID: 21796631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRPM2 ion channel promotes gastric cancer migration, invasion and tumor growth through the AKT signaling pathway.
    Almasi S; Sterea AM; Fernando W; Clements DR; Marcato P; Hoskin DW; Gujar S; El Hiani Y
    Sci Rep; 2019 Mar; 9(1):4182. PubMed ID: 30862883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.